Recent clinical trial results and the decision by the US Food and Drug
Administration to issue 'Emergency Use Authorisation' for remdesivir
have highlighted the urgency of this work and the importance of
planning for access to remdesivir globally, Gilead said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gilead-scouting-for-partners-in-india-pakistan-for-remdesivir/articleshow/75575882.cms
No comments:
Post a Comment